Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial
Clinical trial NCT02275533 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02275533
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-02
- Primary completion
- 2025-07-28
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.